Informatie:
Fout:
Trefwoorden
AML ×
- Clinical Trial (206)
- Leukemia (114)
- Eligibility Determination (85)
- Hematology (37)
- Treatment Form (29)
- Leukemia, Myeloid, Acute (25)
- Laboratories (24)
- Myelodysplastic Syndromes (21)
- Follow-Up Studies (16)
- Routine documentation (14)
- Topotecan (13)
- Physical Examination (12)
- ALL (11)
- EHR (10)
- Therapeutics (9)
- Registries (7)
- Adverse event (7)
- Bone Marrow (6)
- Baseline (6)
- On-Study Form (6)
- Stem Cell Transplantation (5)
- Hematopoietic Stem Cell Transplantation (4)
- Concomitant Medication (4)
- Drug Therapy (4)
- Hematologic Tests (4)
- Multicenter Study (3)
- CML (3)
- Registration (3)
- End of Study (3)
- Medical History Taking (3)
- Pathology (3)
- Recurrence (2)
- Directory (2)
- Off-Treatment (2)
- Clinical Trials as Topic (2)
- Cytogenetics (2)
- Demography (2)
- Internal Medicine (2)
- Medical Oncology (2)
- Molecular Biology (2)
- Neoplasms (2)
- Patient Discharge (2)
- Aspergillus (1)
- Urine (1)
- Comorbidity (1)
- Clinical Trial, Phase I (1)
- Clinical Trial, Phase II (1)
- Blood (1)
- Blood Transfusion (1)
- Bone Marrow Examination (1)
- Transplantation Conditioning (1)
- Clinical Chemistry Tests (1)
- Evaluation Studies (1)
- Donor Selection (1)
- Karyotype (1)
- Common Data Elements (CDE) (1)
- Patient information (1)
- Trial screening (1)
- Disease Status (1)
- Diagnostic Procedure (1)
- Bone marrow biopsy (1)
- SD150101 (1)
- dbGaP (1)
- Daunorubicin (1)
- Death (1)
- Anti-Bacterial Agents (1)
- Neoplasm Staging (1)
Inhoudsopgave
Geselecteerde datamodellen
U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.
269 Zoekresultaten.
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Itemgroepen: Inclusion criteria, Exclusion criteria
Itemgroepen: Default Itemgroup, Patient status, Remission Status, GvHD, AML/MDS Treatment Given after End of Protocol, Comments, Fill in this Page in Case of autoHSCT, alloHSCT or DLI (Given after End of Protocol), Donor, Comments 2
Itemgroepen: Visit 7, Full Blood Count, Clinical Chemistry, Coagulation, Cardiac Enzymes, Response Assessment, Examination of Bone Marrow, Disease Response, Molecular Genetics, Success assessment
Visit 1 - Medical History
6 Itemgroepen 45 Data-elementenVisit 3/4/5/6 (Day 2, 3, 4, 5 Induction I)
5 Itemgroepen 30 Data-elementenVisit 1 Baseline
9 Itemgroepen 124 Data-elementenVisit Registration/Randomization I
5 Itemgroepen 19 Data-elementenVisit 2 (Day 1 Induction I)
4 Itemgroepen 58 Data-elementenVisit Randomization II
4 Itemgroepen 19 Data-elementen Itemgroepen: Adverse Event, Adverse Event related to, Signature
Itemgroepen: Patient data, Diagnosis, Baseline Examinations, Concomitant Medication, ADVERSE EVENTS, Signature
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Itemgroepen: Patientendaten, Differentialblutbild, Knochenmarkuntersuchung, Zytologie, Molekulargenetik, Unterschrift, Patientendaten, Unterschrift
Itemgroepen: Patientendaten, Unerwünschtes Ereignis (AE), Ende AE, Unterschrift
Itemgroepen: Disease Characteristics, Patient Characteristics, Prior Therapy
Itemgroepen: Maintenance, Dasatinib intake during last month (since last visit), Urinalysis, Adverse Event, Concomitant Medication, Signature
Itemgroepen: Default Itemgroup, Patient last seen, Graft versus Host Disease (GvHD) since last report, Chronic Graft versus Host Disease, Other complications since last report, Graft assessment and chimaerism, Chimerism test, Additional therapies since last follow up, First evidence of relapse or progression since last HSCT, Last disease and patient status, Comments, Identification and Signature